The clinical application of serum amyloid A in the diagnosis and treatment of COVID-19
10.3760/cma.j.cn114452-20200528-00507
- VernacularTitle:血清淀粉样蛋白A在新型冠状病毒肺炎诊疗中的应用价值
- Author:
Minye GU
1
;
Guohao GU
;
Yaling SHI
;
Xiaobo HU
;
Jiubo FAN
;
Ying XU
;
Jianxin XU
Author Information
1. 上海即时检测医学工程技术研究中心，上海 201201
- From:
Chinese Journal of Laboratory Medicine
2020;43(9):935-938
- CountryChina
- Language:Chinese
-
Abstract:
Serum amyloid A(SAA) is a novel marker widely used in the acute infection disease, especially viral infection. SAA has shown a cerntain value in assisting the clinical diagnosis, discrimination of severity and monitoring of progress and outcome of COVID-19. This paper introduces the application of SAA structural, function andits dynamic detection in the diagnosis of COVID-19, and the significance of combined detection with COVID-19 antibodies, nucleic acid and other diagnostic indicators.
